Protective immunity to genital herpes simplex virus type 1 and type 2 provided by self-adjuvanting lipopeptides that drive dendritic cell maturation and elicit a polarized Th1 immune response

被引:45
作者
Bettahi, Ilham
Zhang, Xiuli
Afifi, Rasha E.
BenMohamed, Lbachir
机构
[1] Univ Calif Irvine, Sch Med, Coll Med, Cellular & Mol Immunol Lab,Eye Inst, Orange, CA 92868 USA
[2] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92868 USA
关键词
D O I
10.1089/vim.2006.19.220
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Genital herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) infections are a significant health problem worldwide. While it is believed that CD4+ Th1 cells are among the effectors to herpes immunity, developing an epitope-based clinical vaccine capable of inducing an effective anti-herpes CD4+ Th-1-mediated protection is still under investigation. Few molecules achieve this target without the aid of external immuno-adjuvant. The present study was undertaken to examine the immunogenicity in mice of five CD4+ T cell epitope peptides (gD(1-29), gD(49-82), gD(146-179), gD(228-257), and gD(332-358)), recently identified from the HSV-1 glycoprotein D (gD), covalently linked to a palmitic acid moiety (lipopeptides) using the high-yielding chemoselective ligation method and delivered subcutaneously in free-adjuvant saline. Their protective efficacy was evaluated in a progestin-induced susceptibility mouse model of genital herpes following intravaginal challenge with either HSV-1 or HSV-2. Four out of five gD lipopeptides effectively induced virus-specific CD4+ Th-1 responses associated with a reduction of virus replication in the genital tract and protection from overt signs of genital disease. A cocktail of three highly immunogenic lipopeptides; provoked maturation of dendritic cells, induced interferon gamma (IFN-gamma)-producing CD4+ T cells, and protected against both HSV-1 and HSV-2 infections. Depletion of specific T cell subsets from lipopeptideimmunized mice before intravaginal HSV challenges demonstrated that CD4+ T cells were primarily responsible for this protection. The strength of induced T cell immunity, together with the ease of construction and safety of these totally synthetic self-adjuvanting lipopeptides, provide a molecularly defined formulation that could combat genital herpes and other human viral infections for which induction of Th-1 immunity is crucial.
引用
收藏
页码:220 / 236
页数:17
相关论文
共 70 条
  • [1] High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules
    Benmohamed, L
    Thomas, A
    Bossus, M
    Brahimi, K
    Wubben, J
    Gras-Masse, H
    Druilhe, P
    [J]. VACCINE, 2000, 18 (25) : 2843 - 2855
  • [2] Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity
    BenMohamed, L
    Bertrand, G
    McNamara, CD
    Gras-Masse, H
    Hammer, J
    Wechsler, SL
    Nesburn, AB
    [J]. JOURNAL OF VIROLOGY, 2003, 77 (17) : 9463 - 9473
  • [3] Long-term multiepitopic cytotoxic-T-lymphocyte responses induced in chimpanzees by combinations of Plasmodium falciparum liver-stage peptides and lipopeptides
    BenMohamed, L
    Thomas, A
    Druilhe, P
    [J]. INFECTION AND IMMUNITY, 2004, 72 (08) : 4376 - 4384
  • [4] Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses
    BenMohamed, L
    Krishnan, R
    Auge, C
    Primus, JF
    Diamond, DJ
    [J]. IMMUNOLOGY, 2002, 106 (01) : 113 - 121
  • [5] BenMohamed L, 2002, EUR J IMMUNOL, V32, P2274, DOI 10.1002/1521-4141(200208)32:8<2274::AID-IMMU2274>3.0.CO
  • [6] 2-C
  • [7] Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees
    BenMohamed, L
    GrasMasse, H
    Tartar, A
    Daubersies, P
    Brahimi, K
    Bossus, M
    Thomas, A
    Druilhe, P
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (05) : 1242 - 1253
  • [8] Lipopeptide vaccines - yesterday, today, and tomorrow
    BenMohamed, L
    Wechsler, SL
    Nesburn, AB
    [J]. LANCET INFECTIOUS DISEASES, 2002, 2 (07) : 425 - 431
  • [9] Targeting virological core groups: A new paradigm for controlling herpes simplex virus type 2 epidemics
    Blower, S
    Wald, A
    Gershengorn, H
    Wang, F
    Corey, L
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) : 1610 - 1617
  • [10] Simultaneous lipidation of a characterized peptide mixture by chemoselective Ligation
    Bourel-Bonnet, L
    Bonnet, D
    Malingue, F
    Gras-Masse, H
    Melnyk, O
    [J]. BIOCONJUGATE CHEMISTRY, 2003, 14 (02) : 494 - 499